Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection
Clinical trial NCT01597349 · COMPLETED
Trial details
- NCT number
- NCT01597349
- Sponsor
- Avalo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2012-09-01
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.